News & Updates

For many specialty medications, prescribing is the point where patient access breaks down. That’s because physicians write prescriptions without key insights like which benefit applies, if PA is needed, or where to route the script.

When 27% of specialty prescriptions go unfilled due to payer rejections and patient drop-off, it’s crucial to remove these upstream barriers.

Join two chief medical officers for a candid, physician-led conversation about what’s happening in the prescribing workflow and what’s possible when prescribers have the support they need to send clean prescriptions that are ready to fill.

What You’ll Learn

• Why specialty prescriptions fail before your access strategy starts
• What the PA process looks like from the prescriber’s view
• How in-workflow clinical support improves prescription accuracy and time-to-therapy
• How a new framework for access starts at the point of prescribing and strengthens patient engagement downstream

If you’re responsible for market access, brand strategy, or patient outcomes, this conversation will give you a new perspective on how actionable support works in tandem with patient engagement to remove barriers at both ends of the medication journey: before the pharmacy receives it and before the patient abandons it.

Learn how to measure publication impact more effectively, streamline reporting, and make more informed strategic decisions. Request your free white paper now.

Biopharma organizations are generating more data than ever, yet many Medical Affairs teams still struggle to translate that volume into clear, actionable direction. Across the product lifecycle, expanding evidence, rising stakeholder expectations, and increasing competitive complexity are exposing the limits of traditional, fragmented approaches to medical strategy.

In this webinar, medical leaders from across the industry will explore:

• Why current Medical Affairs models are falling short in high-data environments
• What a more integrated, decision-focused approach looks like in practice
• How leading organizations are rethinking the connection between evidence generation, scientific narrative, and strategic decision making

From early planning through launch and beyond, the discussion will highlight how more intentional, forward-looking alignment can sharpen evidence priorities, accelerate narrative clarity, and strengthen Medical Affairs' role as a driver of strategic impact.

What You'll Walk Away With:

• A clear understanding of why more data isn't translating into better strategic decisions
• Insight into where fragmentation occurs across evidence, insights, and planning, and how it impacts execution
• A practical view of how leading organizations are shifting to decision-driven strategy, with approaches to better connect insights, evidence, and scientific narrative

Launch is no longer a one-time commercial milestone. It’s evolving into an agile, lifecycle-wide management system: a continuous series of cross-functional decisions shaped by market access pressure, policy volatility, and fast-moving in-market signals. Fixed launch plans and delayed performance readouts are becoming less viable amid disruptions such as Most-Favored-Nation pricing pressure and ongoing Medicare negotiations.

In this webinar, Inizio Ignite experts will explore what the future of launch requires across strategy, execution, and performance measurement. They will examine how leading organizations are evolving toward adaptive models that:

• Detect risk earlier through in-market signals
• Preserve strategic intent through execution
• Enable faster pivots across stakeholders and field activation
• Strengthen continuous performance measurement

The session highlights how teams can move beyond launch readiness toward a more responsive, lifecycle-driven approach aligned to today’s complex commercial environment.

Most launch success is decided in the first six months, so reps can’t afford to learn on the job. This eBook shares a modern, practical approach to field readiness that aligns training, content, and coaching to ensure confident, consistent day‑one performance. Download now to learn more.

Discover why Puerto Rico is a leading hub for bioscience manufacturing. This white paper explores its strong infrastructure, skilled workforce, and strategic advantages for companies looking to scale operations and strengthen global supply chains.

Foundational code sets like ICD-10 often lack the detail needed for specialty care. This brief explores how advanced terminologies improve clinical accuracy, data quality, and research insights across complex conditions. Download the brief to learn how more precise coding supports better outcomes.

Patient support is at an inflection point. For pharmaceutical manufacturers, improving outcomes now requires more than adding services—it demands a more connected, strategic approach to the patient journey. In this webinar, Archbow Consulting and Omnicom Health Market Access will examine how pharma organizations can move beyond fragmented support models to build orchestrated experiences that reduce access barriers, accelerate time to therapy, and provide greater visibility across the patient journey.

Topics covered include:

• Why fragmentation continues to challenge traditional patient support models
• How to align services, touchpoints, and data around patient needs
• Approaches to designing more integrated, insight-driven support experiences
• Real-world examples of how manufacturers are evolving their models

Why attend:

• Gain practical strategies to strengthen patient support performance
• Learn how orchestration can improve both patient experience and operational efficiency
• Identify opportunities to drive more connected, actionable data across programs

Register now to secure your seat.

Is your AI trustworthy? A growing scientific content challenge is making it difficult to trace the data powering AI. This introduces potential regulatory risks and increases the likelihood of unreliable outputs from large language models.

Join us for this valuable and timely webinar to explore how to navigate the path to audit-ready, grounded AI in drug discovery. You’ll discover practical strategies for moving beyond aspiration toward scalable, real-world implementation.

Learn about:

• How to move from unclear copyright policies to a traceable, audit-ready data foundation using FAIR metadata 
• Actionable tips for transforming fragmented information into connected, usable knowledge 
• Approaches that help anchor outputs to structured, verifiable evidence 
• And more

Don’t miss key insights for ensuring your AI systems are reliable, traceable, and compliant. Register now!